Penicillin Allergy Evaluation: A Prospective, Multicenter, Open-Label Evaluation of a Comprehensive Penicillin Skin...

Area of Science:

• Allergy and Immunology
• Pharmacology
• Infectious Diseases

Background:

• A significant portion of the population is misdiagnosed with penicillin allergy.
• This misdiagnosis leads to increased healthcare costs, prolonged hospital stays, and higher rates of broad-spectrum antibiotic use and drug-resistant infections.
• Currently available penicillin skin test reagents often lack FDA approval and accessibility.

Purpose of the Study:

• To evaluate the negative predictive value (NPV) of a standardized Penicillin Skin Test Kit.
• The kit includes major and minor allergenic determinants and amoxicillin.
• The study aimed to assess the kit's efficacy in identifying true penicillin allergies.

Main Methods:

• A prospective, multicenter, open-label study was conducted.
• Patients with a history of penicillin allergy underwent skin testing.
• Skin test-negative individuals were orally challenged with amoxicillin to assess reactions.

Main Results:

• The Penicillin Skin Test Kit showed a high NPV of 97.9% in identifying patients who could safely tolerate amoxicillin.
• 13.8% of patients tested positive, with most reactions to minor determinants or amoxicillin alone.
• Reactions observed after amoxicillin challenge in skin test-negative patients were predominantly mild.

Conclusions:

• The FDA-standardized Penicillin Skin Test Kit is highly effective in identifying patients who are not truly allergic to penicillin.
• This validated testing can help de-label a majority of misdiagnosed patients.
• Accurate penicillin allergy assessment has significant implications for personal and public health, including antimicrobial stewardship.